2020-Nov-17
MetrioPharm Investor Relations News Update
A Current Publication by Dr. Wolfgang Brysch on the Prevention and Treatment of Covid-19
Dear Shareholders
We are pleased to announce today that Dr. Wolfgang Brysch, in collaboration with a group of international scientists, published a paper on the apparent influence of age on the course of the Covid-19 disease, an immune deficiency often linked to the aging process, the growing, broader understanding of these interconnections, and the emerging potential for the improvement of Covid-19 therapies, using anti-oxidative agents and physical exercise in a complementary fashion.
We would also like to draw your attention to our blog post here.
For further company updates, please also follow our LinkedIn profile here.
Your contact:
|
|
|
| Eva Brysch Head of Investor Relations & Corporate Communications Phone: +49-(0)30-3384-395-40 Mail: invest@metriopharm.com |
